Llorens Josep 4
4 · HAEMONETICS CORP · Filed Jan 25, 2023
Insider Transaction Report
Form 4
Llorens Josep
SVP, Global Manufacturing
Transactions
- Sale
Common Stock
2023-01-23$90.00/sh−2,391$215,190→ 17,234 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2023-01-23−2,391→ 7,173 totalExercise: $56.57From: 2022-05-18Exp: 2028-05-18→ Common Stock (2,391 underlying) - Exercise/Conversion
Common Stock
2023-01-23$56.57/sh+2,391$135,259→ 19,625 total
Footnotes (3)
- [F1]Transaction pursuant to an existing 10b5-1 trading plan.
- [F2]This number includes unvested restricted stock units previously reported.
- [F3]Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.